37 reports

  • Stages of chronic kidney disease
  • Aranesp late-phase trial data in anemia in chronic kidney disease

The launch of novel HIF inhibitor roxadustat will offset biosimilar erosion of Epogen to drive market growth. This report addresses the following questions: - What does the future look like for the erythropoiesis-stimulating agent (ESA)market, considering recent safety data and treatment guidelines? - What are the...

  • Renal Disease
  • Japan
  • United States
  • Amgen Inc.
  • Roche Group
  • Risk Factors and Comorbidities for CKD
  • 4.1 BIBLIOGRAPHY

EpiCast Report: Chronic Kidney Disease - Epidemiology Forecast to 2026 Summary Chronic kidney disease (CKD), or chronic renal disease, is an asymptomatic, long-term condition that damages the kidneys and leads to the loss of kidney function over time (NIH, 2010). As the disease progresses, the symptoms...

  • Chronic Disease
  • Renal Disease
  • United Kingdom
  • United States
  • Forecast

Polycystic Kidney Disease - Epidemiology Forecast to 2027 ##.

  • Renal Disease
  • France
  • Germany
  • Italy
  • Spain

Polycystic Kidney Disease - Market Insight, Epidemiology and Market Forecast - 2027 ##.

  • Chronic Disease
  • Renal Disease
  • United States
  • Market Shares
  • END-STAGE KIDNEY DISEASE (END-STAGE RENAL DISEASE OR ESRD)
  • END-STAGE KIDNEY DISEASE (END-STAGE RENAL DISEASE OR ESRD) THERAPEUTICS CLINICAL TRIALS, ASIA-PACIFIC, TOP FIVE

End-Stage Kidney Disease (end-stage renal disease or ESRD) Global Clinical Trials Review, H1, 2015 Summary GlobalData's clinical trial report, “End-Stage Kidney Disease (end-stage renal disease or ESRD) Global Clinical Trials Review, H1, 2015" provides data on the End-Stage Kidney Disease (end-stage renal disease or ESRD)...

  • Renal Disease
  • United States
  • World
  • Keryx Biopharmaceuticals, Inc.
  • Novartis AG
  • CHRONIC KIDNEY DISEASE (CKD)
  • UPDATES

“Chronic Kidney Disease (CKD) Pipeline Analysis” gives comprehensive insight on the various drugs being developed for the treatment of CKD. The report covers all the drugs being developed in various phases (Discovery, Preclinical, Clinical & Marketing). The pipeline focuses on novel pharmacologic drugs & regenerative medicines covering small...

  • Renal Disease
  • Angion Biomedica Corp.
  • Astellas Pharma Inc.
  • AstraZeneca PLC
  • Eli Lilly & Co.
  • 6. DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES ANALYSIS
  • 4. KEY INFERENCES

The global renal biomarker market is expected to register a good CAGR during 2018-2023 (the forecast period). Kidney disease is a major cause of deaths worldwide. With the increasing incidences of chronic kidney diseases, especially, among the geriatric population, the need for novel biomarkers for early detection of the disease is...

  • Renal Disease
  • United States
  • World
  • Market Size
  • Thermo Fisher Scientific, Inc.
  • End-Stage Kidney Disease (End-Stage Renal Disease or ESRD) - Overview
  • End-Stage Kidney Disease (End-Stage Renal Disease or ESRD) - Dormant Projects, H2 2017

End-Stage Kidney Disease (End-Stage Renal Disease or ESRD) - Pipeline Review, H2 2017 Summary Global Markets Direct’s latest Pharmaceutical and Healthcare disease pipeline guide End-Stage Kidney Disease (End-Stage Renal Disease or ESRD) - Pipeline Review, H2 2017, provides an overview of the End-Stage Kidney Disease...

  • Renal Disease
  • United States
  • World
  • Product Initiative
  • CTI BioPharma Corp.
  • Renal Diseases, Global, Overall
  • Renal Diseases, Global, Percentage

Frontier Pharma: Renal Diseases - High Degree of Innovation and Diversity with Products Targeting Immune and Hormone Signaling Dominating the Pipeline for Chronic Kidney Disease Summary Kidneys are highly specialized organs that maintain a stable internal environment of the body - referred to as homeostasis - by selectively...

  • Chronic Disease
  • Renal Disease
  • World
  • Deals & Alliance
  • Galectin Therapeutics Inc.
  • Polycystic Kidney Disease - Overview
  • Polycystic Kidney Disease - Dormant Projects

Polycystic Kidney Disease - Pipeline Review, H2 2017 Summary Global Markets Direct’s latest Pharmaceutical and Healthcare disease pipeline guide Polycystic Kidney Disease - Pipeline Review, H2 2017, provides an overview of the Polycystic Kidney Disease (Genetic Disorders) pipeline landscape. Polycystic kidney...

  • Renal Disease
  • Therapy
  • United States
  • Company
  • Product Initiative
  • 3.5.9 DIAGNOSED PREVALENT CASES OF DSSC WITH ILD AND CASES WITH KIDNEY DISEASE
  • CASE FLOW MAP OF THE DIAGNOSED PREVALENT CASES OF SSC

EpiCast Report: Systemic Sclerosis (Scleroderma) - Epidemiology Forecast to 2024 Summary Systemic sclerosis (SSc) is an autoimmune disease of the connective tissue, and is characterized by excessive fibrosis, vascular alterations, and the proliferation of antibodies against numerous cellular antigens. SSc mainly affects...

  • Renal Disease
  • France
  • Italy
  • United States
  • Forecast
  • INDUSTRY LIFE CYCLE
  • INTERNATIONAL TRADE

Stable condition: Inelastic demand and technological investments will drive industry expansion AbstractDialysis Centers Dialysis centers in the United States provide patients with kidney disease the necessary services to treat and cope with failing kidneys. Growth in the industry has begun to accelerate...

  • Renal Disease
  • United States
  • Forecast
  • DaVita HealthCare Partners Inc.
  • Fresenius Group

Kidney Disease Global Clinical Trials Review, H##, 2017 Table of Contents ## List of Tables ## List of Figures ## Report Guidance ## GlobalData Clinical Trials Report Coverage ## Clinical Trials by Region ## Clinical Trials and Average Enrollment by Country ## Top Five Countries Contributi

  • Clinical Trial
  • Drug Discovery And Development
  • Pharmaceutical
  • Renal Disease
  • World
  • END-STAGE KIDNEY DISEASE (END-STAGE RENAL DISEASE OR ESRD) THERAPEUTICS CLINICAL TRIALS, CENTRAL AND SOUTH AMERICA, TOP
  • END-STAGE KIDNEY DISEASE (END-STAGE RENAL DISEASE OR ESRD) THERAPEUTICS CLINICAL TRIALS, MIDDLE EAST AND AFRICA, TOP FIVE

End-Stage Kidney Disease (End-Stage Renal Disease or ESRD) Global Clinical Trials Review, H2, 2017 Summary GlobalData’s clinical trial report, “End-Stage Kidney Disease (End-Stage Renal Disease or ESRD) Global Clinical Trials Review, H2, 2017" provides an overview of End-Stage Kidney Disease (End-Stage Renal Disease...

  • Clinical Trial
  • Cytokine
  • Hospital
  • Renal Disease
  • World
  • End-Stage Kidney Disease (End-Stage Renal Disease or ESRD)
  • Jun 06, 2017: Dimerix hosts US key opinion leader meeting with NephCure Kidney International focused on development path of DMX-200 in kidney disease

Chronic Kidney Disease (Chronic Renal Failure) Global Clinical Trials Review, H1, 2017 Summary GlobalData’s clinical trial report, “Chronic Kidney Disease (Chronic Renal Failure) Global Clinical Trials Review, H1, 2017" provides an overview of Chronic Kidney Disease (Chronic Renal Failure) clinical trials scenario....

  • Clinical Trial
  • Hormones
  • Pharmaceutical
  • Renal Disease
  • World
  • Clinical Trial profile. 252 Trial Title

Anemia in Chronic Kidney Disease (Renal Anemia) Global Clinical Trials Review, H1, 2017 Summary GlobalData’s clinical trial report, “Anemia in Chronic Kidney Disease (Renal Anemia) Global Clinical Trials Review, H1, 2017" provides an overview of Anemia in Chronic Kidney Disease (Renal Anemia) clinical trials scenario....

  • Blood Disease
  • Renal Disease
  • World
  • Product Initiative
  • F. Hoffmann-La Roche Ltd.
  • Polycystic Kidney Disease Therapeutics Clinical Trials, Global, Key Sponsors, 2016*
  • Polycystic Kidney Disease Therapeutics, G7 Countries, Clinical Trials by Phase, 2016*

Polycystic Kidney Disease Global Clinical Trials Review, H2, 2016 Summary GlobalData's clinical trial report, “Polycystic Kidney Disease Global Clinical Trials Review, H2, 2016" provides an overview of Polycystic Kidney Disease clinical trials scenario. This report provides top line data relating to the clinical trials...

  • Drug Discovery And Development
  • Genetic Disorder
  • Renal Disease
  • World
  • Product Initiative

Given the high prevalence of kidney disease such as chronic and end-stage renal disease, the availability of resources for meeting the demand is still inadequate, indicating a strong presence of untapped opportunities in the global renal care market.

  • Chronic Disease
  • Healthcare
  • Renal Disease
  • Chile
  • Demand
  • End-Stage Kidney Disease (End-Stage Renal Disease or ESRD) Overview
  • End-Stage Kidney Disease (End-Stage Renal Disease or ESRD) - Therapeutics under Development by Companies

End-Stage Kidney Disease (End-Stage Renal Disease or ESRD) - Pipeline Review, H1 2016 Summary Global Markets Direct’s, ‘End-Stage Kidney Disease (End-Stage Renal Disease or ESRD) - Pipeline Review, H1 2016’, provides an overview of the End-Stage Kidney Disease (End-Stage Renal Disease or ESRD) pipeline landscape. The...

  • Chronic Disease
  • Renal Disease
  • United States
  • Product Initiative
  • Bayer AG
  • Clinical Trial profile. 91 Trial Title
  • Clinical Trial profile. 258 Trial Title

Anemia in Chronic Kidney Disease (Renal Anemia) Global Clinical Trials Review, H2, 2016 Summary GlobalData's clinical trial report, “Anemia in Chronic Kidney Disease (Renal Anemia) Global Clinical Trials Review, H2, 2016" provides an overview of Anemia in Chronic Kidney Disease (Renal Anemia) clinical trials scenario....

  • Blood Disease
  • Erythropoietin
  • Renal Disease
  • World
  • Product Initiative
  • End-Stage Kidney Disease (End-Stage Renal Disease or ESRD) - Overview
  • End-Stage Kidney Disease (End-Stage Renal Disease or ESRD) - Pipeline by VESSL Therapeutics Ltd, H1 2017

End-Stage Kidney Disease - Pipeline Review, H1 2017 Summary Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide End-Stage Kidney Disease - Pipeline Review, H1 2017, provides an overview of the End-Stage Kidney Disease (Genito Urinary System And Sex Hormones) pipeline landscape. End-stage...

  • Pharmaceutical
  • Renal Disease
  • United States
  • World
  • CTI BioPharma Corp.
  • Chronic Kidney Disease (Chronic Renal Failure) - Product Development Milestones
  • CHRONIC KIDNEY DISEASE (CHRONIC RENAL FAILURE) - DISCONTINUED PRODUCTS, H1 2016

Chronic Kidney Disease (Chronic Renal Failure) - Pipeline Review, H1 2016 Summary Global Markets Direct’s, ‘Chronic Kidney Disease (Chronic Renal Failure) - Pipeline Review, H1 2016’, provides an overview of the Chronic Kidney Disease (Chronic Renal Failure) pipeline landscape. The report provides comprehensive...

  • Diabetes
  • Renal Disease
  • United States
  • Company Operations
  • RVX-208 group
  • Polycystic Kidney Disease - Overview
  • Polycystic Kidney Disease - Discontinued Products

Polycystic Kidney Disease - Pipeline Review, H1 2017 Summary Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Polycystic Kidney Disease - Pipeline Review, H1 2017, provides an overview of the Polycystic Kidney Disease (Genetic Disorders) pipeline landscape. Polycystic kidney disease...

  • Renal Disease
  • Therapy
  • United States
  • Company
  • Product Initiative
  • DRUG FOR KIDNEY DISEASES - DRUG PROFILE
  • SMALL MOLECULES FOR CHRONIC KIDNEY DISEASE - DRUG PROFILE

Chronic Kidney Disease - Pipeline Review, H1 2017 Summary Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Chronic Kidney Disease - Pipeline Review, H1 2017, provides an overview of the Chronic Kidney Disease (Genito Urinary System And Sex Hormones) pipeline landscape. Chronic...

  • Diabetes
  • Genitourinary System Disease
  • Renal Disease
  • United States
  • Product Initiative

Polycystic Kidney Disease - Pipeline Insight, 2018 ##.

  • Renal Disease
  • Therapy

End-Stage Kidney Disease - Pipeline Insight, 2018 ##.

  • Renal Disease
  • Therapy
  • AUG 16, 2017: US PROMARKERD PATENT EXPANDED TO ALL KIDNEY DISEASE
  • DEC 16, 2016: DIABETIC KIDNEY DISEASE PATENT GRANTED IN RUSSIA

Summary Proteomics International Laboratories Ltd (Proteomics International), a wholly-owned subsidiary and trading name of PILL, is a medical technology company, which focuses on proteomics, the study of structure and function of proteins. The company harnesses its proprietary proteomics-based technology platform to work...

  • Diabetes
  • Laboratory
  • Proteomics
  • Renal Disease
  • GlobalData's company
  • POLYCYSTIC KIDNEY DISEASE
  • Diabetes and Digestive and Kidney Diseases, 2015*

Polycystic Kidney Disease Global Clinical Trials Review, H1, 2015 Summary GlobalData's clinical trial report, “Polycystic Kidney Disease Global Clinical Trials Review, H1, 2015" provides data on the Polycystic Kidney Disease clinical trial scenario. This report provides elemental information and data relating to the clinical...

  • Pharmaceutical
  • Renal Disease
  • World
  • Product Initiative
  • Otsuka Pharmaceutical Co., Ltd.
  • Chronic Kidney Disease (Chronic Renal Failure) - Overview
  • CHRONIC KIDNEY DISEASE (CHRONIC RENAL FAILURE) - PIPELINE BY EVOTEC AG

Renal Cluster Drug Development Pipeline Review, 2017 Summary This report provides an overview of the renal cluster pipeline landscape. The report provides comprehensive information on the therapeutics under development and key players involved in therapeutic development for Kidney Fibrosis, Chronic Kidney Disease (Chronic...

  • Chronic Disease
  • Renal Disease
  • United States
  • Company
  • Product Initiative
  • Rising prevalence of kidney disease
  • RISING PREVALENCE OF KIDNEY DISEASES IS A MAJOR FACTOR DRIVING THE

Kidney Function/Renal Function market is projected to grow at a CAGR of 6.1%. The global kidney function tests market is expected to reach USD 790.1 million by 2022 from USD 586.5 million in 2017 at a CAGR of 6.1% during the forecast period. Factors such as the rising prevalence of kidney disease, growing prevalence of...

  • In Vitro Diagnostics
  • Renal Disease
  • North America
  • United States
  • Sysmex Corporation